 SOPHiA Genetics SA is set up for a public debut Friday, as the Switzerland-based data-driven medicine companys initial public offering price overnight at 18 a share, which was in the middle of the expected range of between 17 and 19 a share. The company sold 13.0 million shares in the IPO to raise 234 million, with the IPO pricing valuing the company at about 1.14 billion. 